Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Drug utilization for tnfα inhibitors in us medicaid program: a retrospective analysis 1998-2016
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: HINCAPIE, Ana (University Of Cincinnati College of Pharmacy, 1984)
- Co-author(s): Ana Hincapie
Valerie Hughes: University Of Cincinnati College of Pharmacy, Cincinnati, United States
Jeff Guo: University Of Cincinnati College of Pharmacy, Cincinnati, United States
BackgroundTreatment options for rheumatoid arthritis and other autoimmune diseases significantly changed after approval of TNFα inhibitors in 1998. This advancement was accompanied by high prescription price and excelling economic performance.
MethodsUsing the Centers for Medicare and Medicaid Services (CMS) national pharmacy data, pharmacy.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 13 May 2019